Brief Reports Open Access
Copyright ©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 7, 2005; 11(13): 2004-2008
Published online Apr 7, 2005. doi: 10.3748/wjg.v11.i13.2004
Traditional Chinese medicine syndromes of chronic hepatitis B with precore mutant
Hong-Zhi Yang, Min Dai, Yong-Wei Li, Yong-Ze Wang, Wei-Bing Guan, He-Ping Xie, Department of Traditional Chinese Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, Guangdong Province, China
Jian-An Zhao, Department of Acupuncture and Moxibustion, Shaanxi Hospital of TCM, Xi’an 710003, Shaanxi Province, China
Author contributions: All authors contributed equally to the work.
Supported by the Foundation of TCM Administration Bureau, Guangdong Province, No. 100115
Correspondence to: Hong-Zhi Yang, Department of Traditional Chinese Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, Guangdong Province, China. 87507880@gdvnet.com
Telephone: +86-13318815024
Received: September 13, 2004
Revised: September 14, 2004
Accepted: October 26, 2004
Published online: April 7, 2005

Abstract

AIM: This study aims at exploring the distribution of TCM syndromes in CHB patients with HBV pre-core mutation (1896) and the relationship between pre-core mutation and T lymphocytes subgroup, through which to provide objective data on clinical syndrome differentiation of TCM, and further to suggest the therapeutic principle and guide clinical treatment.

METHODS: One hundred and forty CHB patients were evenly divided into two study groups, HBV pre-core mutant group and HBV pre-core wild-type group. Besides, 30 healthy blood donors were selected as a healthy control group. HBV-labeled compound, T lymphocytes subgroup, and HBV-DNA pre-core mutant were tested in the study groups. T lymphocytes subgroup were also tested in the control group. All the patients were both diagnosed by syndrome differentiation of TCM and western medicine.

RESULTS: The most common syndrome in mutant group was damp-heat combined with blood stasis, and the most common syndrome in the wild-type group was damp-heat stasis in the middle-jiao. There were more cases of medium and severe hepatitis in mutant group than that in wild-type group. The content of CD4+ lymphocytes and CD4+/CD8+ ratio were decreased gradually (healthy control group>wild-type group>mutant group). In the wild-type group, severe and medium CHB patients had considerably lower level of them than mild CHB patients. However, in the mutant group, the opposite result appeared. Meanwhile, the content of HBV-DNA in mutant group was higher than that in wild-type group.

CONCLUSION: Damp, heat, toxin and blood stasis were the basic pathogens of CHB, whether pre-core mutant or not. CHB with precore mutant may lead to more severe hepatitis. The decreased content of CD4+ lymphocytes and ratio of CD4+/CD8+ may be taken as one of the indices in confirming the deficiency syndrome of CHB patients with pre-core mutation.

Key Words: Traditional Chinese medicine; Syndrome differentiation; Chronic hepatitis B; Pre-core mutant; T lymphocytes subgroup



INTRODUCTION

With the development of research on HBV pre-core gene mutation (1896), it is noticed that pre-core mutant cases were frequently encountered in clinics. One of the studies in China showed that the rate of pre-core mutation was 56% in CHB patients with anti-HBe antibody in serum[1]. Taiwanese researchers reported a rate of 67% in CHB patients with HBeAg-negative[2]. In a study by Japanese scholars, the rate of pre-core mutation in 46 patients with HBsAg and anti-HBe-positive was up to 100%[3]. One study showed that the fibrosis state of liver in CHB patients with pre-core mutant was more severe when compared with those without mutation, hence it was considered that the mutation may be related to disease progression as well as the lack of patients’ response to therapy[4]. Studies also found that CHB patients without pre-core mutant strain before treatment was more responsive to IFN-α[5]. In one sequential combination therapy, most of the patients with pre-core mutation relapsed within 4 mo after treatment, suggesting that trials of patients with HBeAg negative should be based on characterization of HBV mutants[6]. Many studies supported that HBV pre-core mutant was closely correlated to the occurrence of severe hepatitis and hepatocellular carcinoma (HCC)[7-10]. Moreover, researchers have pointed out that the relapse rate was considerably higher among patients with the pre-core mutant than the ones with non-precore mutant after medical operation[11]. Studies also showed that there was close relationship between HBV pre-core mutation and severe hepatitis in those HCC patients involved in HBV infection during the chemo-therapy[12,13]. Among those patients with severe CHB, studies revealed a mutation rate as high as 88.89%, with a relatively higher content of HBV-DNA in serum[14]. At present, much work has been done about the study on HBV pre-core mutation, and quite many diseases related to HBV infection were found aggravated due to HBV pre-core mutation, which has brought a new challenge to the prophylaxis and therapies of hepatitis B and HBV-related diseases[15-18]. Since there is less work done on the study of HBV pre-core gene mutation (1896) with CHB patients in the way of TCM sciences, we made the study on CHB patients in respect of HBV pre-core gene mutation, syndrome types of TCM, diagnosis of western medicine, content of HBV-DNA, T lymphocytes subgroup and virus replication capacity. The distribution characteristics of TCM syndromes in the patients and the pathogenesis according to Chinese medical theories were studied so as to provide objective data to clinical syndrome differentiation of TCM, and further to suggest the therapeutic principle of TCM and guide the treatment in clinic.

MATERIALS AND METHODS
Subjects

Random sampling of 70 HBV-DNA pre-core mutant patients and 70 wild-type patients were taken as two study groups, 30 healthy blood donors as healthy control group. The ratio of sex, mean age and its range in three groups were shown in Table 1. No significant difference of age and sex was between three groups (P>0.05). In the two study groups, the selected 140 patients were in accord with the following criteria: (1) All the patients sought medical advice in the TCM Department of the Third Affiliated Hospital to Sun Yat-Sen University during the period from February, 1999 to December, 2002; (2) patients’ western medicine diagnosis was based on the diagnostic standards defined by three joint committees of Chinese Medical Association: Infectious Diseases Committee, Parasitic Disease Committee and Hepatopathy Committee[19].

Table 1 The cases, sex, and age of three groups.
nRation of sex (M:F)Age (yr)
MeanRange
Mutant7011:0329.10±1.0218-56
Wild-type7061:928.96±0.8317-57.5
Healthy control305:128.85±1.4017-55
Methods and items of examination

The indicators of HBV, HBV-DNA precore mutant and the HBV-DNA content were analyzed.

HBV-DNA content The method of fluorescence quantitative PCR was applied in HBV-DNA content. The reagent was provided by Da An Gene Corp Affiliated to Sun Yat-Sen University, using USA PE5700 automatic analytical machine. The sensitivity is 1×104 copy/mL. See the principle and methods in Ref.[20].

Test of HBV-DNA pre-core mutation (1896) PCR method was used, primer was designed by the laboratory of infection department in our hospital, and synthesized by Shanghai Biological Institute. See the principle and methods in the reference[21].

T lymphocytes subgroup (CD4+,CD8+,CD4+/CD8+) check up APAAP techniques[22] were employed. The reagent was supplied by Fundamental Medicine Institution, Academy of Military Medical Sciences.

Traditional chinese medicine differential syndromes

TCM differential syndromes referred to the viral hepatitis diagnostic standards defined in December, 1991 by Internal Medicine Hepatopathy Committee of Chinese Traditional Medicine Association[23]. Patients with viral hepatitis were accordingly, classified into five subtypes: (a) Damp heat stasis in the middle-jiao; (b) Liver Qi stagnation and spleen deficiency; (c) Yin deficiency of liver and kidney; (d) Blood stasis into collateral; (e) Yang deficiency of spleen and kidney. See the diagnostic standards in Ref.[23]. Besides, based on the clinical manifestation, a new type of damp heat complicated with blood stasis was added.

Statistical analysis

SPSS 11.0 statistic software was adopted in analyzing all the materials. Different groups of variable were explored by the method of variant analysis. When variant fluctuation was limited, LSD method was applied, otherwise, Dunnett’s T3 check was used.

RESULTS
Distribution of syndrome-types based on TCM and western medical diagnosis in mutant and wild-type groups (Table 2)
Table 2 Distribution of syndrome-types based on TCM in mutant and wild-type groups.
SubtypePre-core Mutant
-+
DHSM3617
LSSD712
YDLK75
BSIC47
DHBS1125
YDSK54
Mild hepatitis4123
Medium hepatitis2239
Severe hepatitis78

Distribution of TCM syndromes was apparently different between the two study groups (χ2 = 7.44, P = 0.006). The most common syndrome in mutant group was damp-heat combined with blood stasis (n = 25), and the most common syndrome in the wild-type group was damp-heat stasis in the middle-jiao (n = 36). There was no significant difference in the other syndromes. The cases including medium and severe hepatitis were 29 in wild-type group, however, which were up to 47 in mutant group (P = 0.004).

T lymphocytes subgroup and HBV-DNA

The content of CD4+ lymphocytes and the ratio of CD4+/CD8+ in mutant group were less than that in wild-type group (P<0.05) and the control group (P<0.01). The content of HBV-DNA in mutant group was higher than that in wild-type group (P<0.05) (Table 3).

Table 3 Variant analysis between three groups and Dunnett-t test.
GroupsCasesMean±SD
CD4+Control group3038.27±4.00
Wild-type group7029.9±6.14ab
Mutant group7028.69±5.38b
CD8+Control group3023.9±2.96
Wild-type group7022.4±4.60
Mutant group7023.53±4.80
CD4+/CD8+Control group301.59±0.163
Wild-type group701.36±0.31ab
Mutant group701.26±0.28b
DNAWild-type group704.94±1.16a
Mutant group705.89±1.88
T lymphocytes subgroup comparison in wild-type group itself (Figure 1)
Figure 1
Figure 1 T lymphocytes subgroup comparison in wild-type group itself.

The content of CD4+ lymphocytes and the ratio of CD4+/CD8+ in mild and medium hepatitis were significantly higher than that in severe hepatitis (P<0.001). No significant statistical difference in CD8+ lymphocytes (P>0.05) was found.

T lymphocytes subgroup comparison in mutant group itself (Figure 2)
Figure 2
Figure 2 T lymphocytes subgroup comparison in mutant group itself.

Figure 2 showed that on the contrary of the wild-type group, the content of CD4+ lymphocytes and the ratio of CD4+/CD8+ in medium and severe hepatitis were significantly higher than that in mild hepatitis (P<0.001). No significant statistic difference in CD8+ lymphocytes (P>0.05) was found.

Comparison of DNA content in mutant group and wild-type group (Table 4)
Table 4 Comparison of DNA content in mutant group and wild-type group.
Mean±SD
Mutant groupMild5.934±1.936
Medium5.558±1.687
Severe6.661±2.128
Wild-type groupMild4.664±1.1361
Medium4.999±1.196
Severe5.445±0.975

Although mutant group had a relatively stronger HBV-DNA copy capability than wild-type group, there was no significant difference between the two groups according to the severity of hepatitis (P>0.05) (Table 4).

DISCUSSION

Numerous studies on HBV precore mutation are being made in the way of modern medicine. It has been found that the patients with HBV precore mutation are subjected to develop not only severe hepatitis but also HCC[3,24-26]. Therefore when doctors treat these patients, they should pay attention to more questions. It is considered in modern medical sciences that HBV precore mutation is mainly caused by high immune pressure of human organism. The HBV are not eliminated but continue to reduplicate through mutation and evasion of the distinction of host immune system. In traditional Chinese medicine, HBV are regarded as a mixture of damp, heat and toxin, which restrains Yang Qi, goes deeply into the blood, internal organs and collaterals. A disease caused by these pathogens has usually a long course and is often lingering and difficult to cure. Therefore, damp, heat, and toxin are the basic pathogens and exist during the whole development course of CHB. Our study showed that, in the mutant group, damp-heat combined with blood stasis was mostly often seen, followed by damp-heat stasis in the middle-jiao. These two syndromes occupied 67% (47/70) of the total cases in this group. These two syndromes also occupied 60% (42/70) of the total cases in wild-type group. So, our study showed that damp, heat, toxin and blood stasis were the basic pathogenic factors of CHB, whether pre-core mutant or not. According to the western medical diagnosis of two study groups, our study found that there was close relationship between pre-core mutant and the severity of hepatitis, just like quite other studies that had already reported[4,11,14]. These patients usually had a long course and presented hypochondriac pain, jaundice, dark urine, loose stool, etc. Therefore, we consider that the nature of damp, heat, toxin and blood stasis does not change though with HBV mutant, and the mutation is possibly the result of the conflict of antipathogenic Qi and pathogenic Qi.

Concerning the question of why hepatitis B could easily turn into CHB, most of the researchers believe that it is because of the host’s immune malfunction and partial or full immunologic tolerance to various HBV antigens. Therefore, T lymphocytes play a very important role in the process of HBV chronic infection. CD4+ cells and CD8+ cells are a main part in the T lymphocytes subgroup. Under normal conditions, they are in a state of balance. If the balance is broken, it will lead to cell immunopotency decrease, immune regulation dysfunction, and consequently, HBV chronic infection. In severe hepatitis-B, the infective rate of HBV mutant strain was high. The mutant strain induces more severe immune disorders in host, resulting in the release of cytokines, so liver damage is more prominent[13]. Studies in modern TCM clinical treatment support that the cellular immune function of human body accord with “antipathogenic Qi”. The “coexistence of weakened antipathogenic Qi and excessive pathogenic Qi” is one of the manifestations of decreased cellular functionality. Vigorous antipathogenic Qi results in a more intense conflict between the two Qi, and a more violent immune reaction which explains the formation of acute disease. On the other hand, deficient antipathogenic Qi and decreased immune functionality cause the disease prolonged uncured and turned to be chronic and lingering. Da and Chen[27] classified CHB patients as deficiency syndrome, excess syndrome and deficiency complicated with excess syndrome. He made a comparison among the three syndromes in respect of cellular immune functionality. Results showed a significantly higher content of CD4+ lymphocytes and CD8+ lymphocytes in excess syndrome group, but there was no significant difference between deficient and excess groups in contrast with the deficiency complicated with excess syndrome group, suggesting a possibly lowered functional level of the assistant T lymphocytes in deficiency syndrome and a predominant immune reaction depending on the cytotoxic T lymphocytes in excess syndrome. Numerous research have showed that the content of CD4+ lymphocytes and the ratio of CD4+/CD8+ could be greatly increased by strengthening antipathogenic Qi of the CHB patients. Zhang et al[28], prescribed Ginseng-Astraglus Four Ingredients Decoction to cure CHB patients, which significantly increased the content of CD4+ lymphocytes and the ratio of CD4+/CD8+. He pointed out that the CHB patients could be differentiated as blood deficiency syndrome and treated with Chinese herbs functioning in supplementing antipathogenic Qi and blood. Our research demonstrated considerably higher content of CD4+ lymphocytes and ratio of CD4+/CD8+ in control group than that in two study groups, which was in line with most of the document reported. Low content of CD4+ lymphocytes and ratio of CD4+/CD8+ of the CHB patients was regarded as one of the indices of deficiency syndrome. Lack of antipathogenic Qi is the essential reason of human disease. Cite the chapter “Discussion on Acupuncture Method” in plain question: “Pathogenic Qi is difficult to invade if antipathogenic Qi is sufficient in human body”. Only when antipathogenic Qi is relatively weak and unable to defeat pathogenic Qi, the invasion of pathogenic Qi becomes possible, which leads not only to the imbalance of Yin and Yang but also the dysfunction of viscera and meridians, consequently, the occurrence of diseases. For the CHB patients with pre-core mutation, antipathogenic Qi is not strong enough to fight against pathogenic Qi, so that HBV could evade immune attack through mutating and is not eliminated in time and its reduplication multiplies, which can explain why HBV-DNA content is higher in pre-core mutant positive group than in negative group. Meanwhile, the intensity of the conflict of the antipathogenic Qi and the pathogenic Qi, together with the power of antipathogenic Qi, determines the state of patients’ condition. The more intense the fight, the stronger the immune system reacts, and the liver cells are greatly damaged. During this stage, the excess syndrome is predominant and vice versa. With long-term conflict between the antipathogenic Qi and the pathogenic Qi, the antipathogenic Qi becomes weaker and weaker, which can explain why the content of CD4+ lymphocytes and the ratio of CD4+/CD8+ in the mutant group was less than that in the wild-type group. For CHB patients with precore mutation, it is the common case that the weakness of antipathogenic Qi and the vigor of pathogenic Qi gradually develop into blood stasis, even liver cirrhosis and HCC come into existence. Added with the imbalance of the seven emotional factors (joy, anger, melancholy, brooding, sorrow, fear and shock) and the imbalanced daily regimen, patients’ condition will soon deteriorate if no prompt medical treatment or erroneous treatment is given. It may explain why the patients with severe hepatitis is more often seen in those patients with precore mutation. Therefore, we consider that those patients with precore mutation should be differentiated as deficiency complicated with excess syndrome. Because of the coexistence of weakened antipathogenic Qi and excessive pathogenic Qi, HBV can evade from immune through mutation and the HBV reduplication capacity becomes vigorous, which result in disease lingering. When patients’ condition is in the mild stage, the syndrome of deficiency complicated with excess should be considered, while in severe stage, excess syndrome manifested should be focused on. Clinical treatment should rely on the indices of CD4+ and CD4+/CD8+, strengthening antipathogenic Qi and eliminating pathogenic factors according to the state of the patients. Attentively, tonic herbs should not be misused, which may aggravate patients’ condition.

Footnotes

Science Editor Li WZ Language Editor Elsevier HK

References
1.  Guo YH, Yan XJ, Ren FL, Cui DX, Hou Y, Zhao JR, Han FC, Su CZ. The clinical significance of the HBV precore mutant examination in Asian patients suffered with HBV. Shijie Huaren Xiaohua Zazhi. 1999;7:800-801.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Lin CL, Liao LY, Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B. J Gastroenterol. 2002;37:283-287.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 34]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
3.  Shindo M, Hamada K, Koya S, Sokawa Y, Okuno T. The clinical significance of core promoter and precore mutations during the natural course and interferon therapy in patients with chronic hepatitis B. Am J Gastroenterol. 1999;94:2237-2245.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 19]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
4.  Sakhuja P, Malhotra V, Gondal R, Sarin SK, Guptan R, Thakur V. Histological spectrum of chronic hepatitis in precore mutants and wild-type hepatitis B virus infection. Trop Doct. 2004;34:147-149.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Seo Y, Yoon S, Hamano K, Nakaji M, Yano Y, Katayama M, Ninomiya T, Hayashi Y, Kasuga M. Response to interferon-alpha in chronic hepatitis B with and without precore mutant strain detected by mutation site-specific assay. J Clin Gastroenterol. 2004;38:460-464.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 8]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
6.  Schiefke I, Klecker C, Maier M, Oesen U, Etzrodt G, Tannapfel A, Liebert UG, Berr F. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a. Liver Int. 2004;24:98-104.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 12]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
7.  Shiraki K, Hamada M, Sugimoto K, Ito T, Yamanaka T, Wagayama H, Shimizu A, Makino Y, Takase K, Nakano T. Detection of precore-mutant hepatitis B virus genome in patients with acute and fulminant hepatitis using mutation site-specific assay (MSSA). Hepatogastroenterology. 2002;49:1352-1356.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Zhong S, Chan JY, Yeo W, Tam JS, Johnson PJ. Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues. J Viral Hepat. 2000;7:115-123.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 27]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
9.  Wang JY, Liu P. Abnormal immunity and gene mutation in patients with severe hepatitis-B. World J Gastroenterol. 2003;9:2009-2011.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Kobayashi M, Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Suzuki F, Akuta N, Hosaka T. Precore wild-type hepatitis B virus with G1896 in the resolution of persistent hepatitis B virus infection. Intervirology. 2003;46:157-163.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 12]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
11.  Kubo S, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Yamamoto T, Ikebe T, Wakasa K, Nishiguchi S, Kinoshita H. Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma. Cancer. 2000;88:1016-1024.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 5]  [Reference Citation Analysis (0)]
12.  Dai MS, Lu JJ, Chen YC, Perng CL, Chao TY. Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients. Cancer. 2001;92:2927-2932.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 2]  [Reference Citation Analysis (0)]
13.  Ito S, Nakazono K, Murasawa A, Mita Y, Hata K, Saito N, Kikuchi M, Yoshida K, Nakano M, Gejyo F. Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient. Arthritis Rheum. 2001;44:339-342.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 2]  [Reference Citation Analysis (0)]
14.  Dai W, Guo YB, Yang DG, Tang W, Yuan J, Wang ZQ, Su D. Relationship of HBV precore mutation with the serum HBV DNA in the patients with chronic HBV infection. Linchuang Gandanbing Zazhi. 2001;17:152-153.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Hernández JA, Diloy R, Salat D, del Río N, Martínez X, Castellví JM. Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab. Haematologica. 2003;88:ECR22.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Li LJ, Ruan B, Dennin RH, Wo JE, Chen Z, Chen YG. Mutations in precore and core promoter region of HBV in patients with hepatic failure. Hepatobiliary Pancreat Dis Int. 2002;1:63-67.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Ni YH, Chang MH, Hsu HY, Tsuei DJ. Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinoma. Gut. 2003;52:122-125.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 36]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
18.  Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet. 2002;359:1488-1489.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 50]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
19.  The Chinese Guideline of Viral Hepatitis. Defined by the 3 joint committees of Chinese Medical Association: Infectious Diseases Committee, Parasitic Disease Committee and Hepatopathy Committee. Zhonghua Ganzangbing Zazhi. 2000;8:324-329.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Chen G, He YS, Zhou XY. Fluorescence quantitative PCR and its application in detection of hepatitis B virus. Zhonghua Yixue Jianyan Zazhi. 1999;22:135-138.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Gao ZL, Yao JL, Guo WL. Detection the pre-core mutant of HBV by changing the 3'end of primer. Zhonghua Ganzangbing Zazhi. 1997;5:176-177.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Jiang H, Cai M. Improved APAAP immunocytochemical staining-trace cytotoxicity test plate method for detection of cell surface antigens. HuaXi YiKe DaXue XueBao. 2001;32:143-144, 147.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  The standards of TCM differential syndromes of viral hepatitis. Defined in Dec. 1991 by Internal Medicine Hepatopathy Committee of Chinese Traditional Medicine Association. .  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Zhong S, Chan JY, Yeo W, Tam JS, Johnson PJ. Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues. J Viral Hepat. 2000;7:115-123.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Steinberg JL, Yeo W, Zhong S, Chan JY, Tam JS, Chan PK, Leung NW, Johnson PJ. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role. J Med Virol. 2000;60:249-255.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 2]  [Reference Citation Analysis (0)]
26.  Chen PM, Yao NS, Wu CM, Yang MH, Lin YC, Hsiao LT, Yen CC, Wang WS, Fan FS, Chiou TJ. Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation. Transplantation. 2002;74:182-188.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 22]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
27.  Da KN, Chen Y. The relationship between T lymphocytes subgroup and Traditional Chinese Medicine differential syndromes in chronic hepatitis B. Nantong Yixuebao. 1995;15:291-292.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Zhang YL, Yue YE, Li SG, Zhao JP. ShenQi SiWu Tang to cure Chronic Hepatitis B patients and observation of T lymphocytes subgroup. Zhongyi Zazhi. 1995;15:236-237.  [PubMed]  [DOI]  [Cited in This Article: ]